While other semaglutide-based injections exist including Ozempic, Wegovy is unique in that it is explicitly approved for weight loss at 2.4mg/week
Factors such as kidney function, liver health, cardiovascular status, and history of hypoglycaemia will influence recommendations
Its a major antioxidant in cells and is involved in many cellular processes
When these pathways are disrupted such that total cellular iron levels rise, the pro-oxidant environment induces excessive lipid peroxidation, most notably of the fatty acyl moieties on phospholipids of poly unsaturated fats, resulting plasma membrane permeabilization and lytic cell death (150)
Researchers are finding more indications every day for patients to take these weight loss medications
Clinical trials (LEADER, SUSTAIN-6, VERTIS-CV) demonstrate benefit across BMI ranges and cardiometabolic profiles